Recently, the 2019 World Medical Innovation Conference (2019 World-Class Hospital and Specialist Construction Innovation Development Conference) was held in Beijing. The conference announced the "2019 Top 100 Most Influential Pharmaceutical Groups in China", and CSPC was honorably on the list.
The theme of this conference is "New Era, New Aspiration, New Creation, New Brilliant". According to reports, the industry voting by all the participants at the conference is only the second stage of the selection activity. In the first stage, the WeChat public voting stage, this selection activity gathered a total of 26.786 million WeChat public votes from 3266613 people. The number of participants and the number of votes have reached a record high since the inception of the 2016 selection.
CSPC has been committed to becoming a globally respected and respected innovative pharmaceutical company. Currently, CSPC has more than 10 pharmaceutical production bases in Hebei, Shanxi, Shandong, Jiangsu, Jiangsu, Tianjin and other provinces and cities, and its products are sold in more than 100 countries and regions in the world. In Shijiazhuang, Beijing, Shanghai and the United States California, Preston, Texas, and New Jersey all have R & D centers and clinical centers. They have contributed Xuanning, Orinin, Jinyouli, Dumexin, Nolinin, and Kelly. New drug products.
In the future, CSPC will provide more, newer and better medicines to the society to benefit more diseases, and make unremitting efforts to lead Chinese pharmaceutical companies to go abroad and expand the international influence of China's pharmaceutical industry.